Compare BNTX & CPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | CPAY |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | Germany | United States |
| Employees | N/A | 11800 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5B | 22.5B |
| IPO Year | 2019 | 2010 |
| Metric | BNTX | CPAY |
|---|---|---|
| Price | $90.32 | $321.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $134.15 | ★ $378.91 |
| AVG Volume (30 Days) | ★ 989.4K | 680.5K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.59 |
| EPS | N/A | ★ 15.03 |
| Revenue | N/A | ★ $4,528,403,000.00 |
| Revenue This Year | N/A | $18.85 |
| Revenue Next Year | $2.61 | $10.52 |
| P/E Ratio | ★ N/A | $22.00 |
| Revenue Growth | N/A | ★ 13.93 |
| 52 Week Low | $79.81 | $252.84 |
| 52 Week High | $124.00 | $361.99 |
| Indicator | BNTX | CPAY |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 46.22 |
| Support Level | N/A | $315.68 |
| Resistance Level | $112.30 | $338.47 |
| Average True Range (ATR) | 3.39 | 12.03 |
| MACD | -2.18 | -1.73 |
| Stochastic Oscillator | 31.27 | 26.27 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. The company offers payment and spend management solutions, including accounts payable automation, cross-border payments, commercial card programs, vehicle payment solutions, and lodging payment services. Its reportable segments are: Corporate Payments, Vehicle Payments, Lodging Payments and Other. The majority of the company's revenue is derived from the Vehicle Payments segment, which helps customers to pay for vehicle related expenses. Geographically, it derives the maximum revenue from the United States and the rest from Brazil, the United Kingdom and other countries.